The Global Governance of HIV/AIDS

Edited by Obijiofor Aginam, John Harrington and Peter K. Yu

in Books from Edward Elgar Publishing

Abstract: The Global Governance of HIV/AIDS explores the implications of high international intellectual property standards for access to essential medicines in developing countries. With a focus on HIV/AIDS governance, the volume provides a timely analysis of the international legal and political landscape, the relationship between human rights and intellectual property, and emerging issues in global health policy. It concludes with concrete strategies on how to improve access to HIV/AIDS medicines.

Keywords: Development Studies; Law - Academic; Politics and Public Policy (search for similar items in EconPapers)
Date: 2013
ISBN: 9781849804905
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.elgaronline.com/view/9781849804905.xml (application/pdf)
Our link check indicates that this URL is bad, the error code is: 503 Service Temporarily Unavailable

Chapters in this book:

Ch 1 Introduction , pp 1-13

Obijiofor Aginam and John Harrington

Ch 2 Communitarian globalism and disease: A normative orientation for global health , pp 14-28

Obijiofor Aginam

Ch 3 Is AIDS treatment sustainable? , pp 29-56

Kenneth C. Shadlen

Ch 4 Access to paediatric medicines: The global political economy of drug production and supply for children in the developing world , pp 57-86

Avram Denburg and Kelley Lee

Ch 5 Trade agreements, intellectual property and access to essential medicines: What future role for the right to health? , pp 87-108

James Harrison

Ch 6 Re-visiting the patents and access to medicines dichotomy: An evaluation of TRIPs implementation and public health safeguards in developing countries , pp 109-130

Tahir Amin

Ch 7 Seizure of generic pharmaceuticals in transit based on allegations of patent infringement: A threat to international trade, development and public welfare , pp 131-141

Frederick M. Abbott

Ch 8 Patent licensing strategies for the research and development of pharmaceuticals in developing countries , pp 142-184

Gail E. Evans

Ch 9 Increasing access through incentives for innovation: The Health Impact Fund , pp 185-199

Laura Biron

Ch 10 Building IPC4D to promote access to essential medicines , pp 200-222

Peter K. Yu

Ch 11 The global governance of HIV/AIDS and the rugged road ahead: An epilogue , pp 223-231

Peter K. Yu

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:elg:eebook:14170

Ordering information: This item can be ordered from
http://www.e-elgar.com

Access Statistics for this book

More books in Books from Edward Elgar Publishing
Bibliographic data for series maintained by Darrel McCalla ().